A Long-Term, Prospective, Observational Study to Evaluate the Safety, Including Cardiovascular Safety, of Fremanezumab in Patients with Migraine in Routine Clinical Practice (TV48125)

A Long-Term, Prospective, Observational Study to Evaluate the Safety, Including Cardiovascular Safety, of Fremanezumab in Patients with Migraine in Routine Clinical Practice

Sponsor(s)
Teva Pharmaceuticals
Principal Investigator(s)
Dr. Amanda Tinsley
Contact Phone Number
Request Information
Address

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

6 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.